<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01810874</url>
  </required_header>
  <id_info>
    <org_study_id>STELLA</org_study_id>
    <nct_id>NCT01810874</nct_id>
  </id_info>
  <brief_title>STELLA Trial: Transperitoneal vs. Extraperitoneal Approach for Laparoscopic Staging of Endometrial/Ovarian Cancer</brief_title>
  <acronym>STELLA</acronym>
  <official_title>STELLA Trial: Staging of Endometrial and Ovarian Cancer Comparing the Transperitoneal vs. Extraperitoneal Approach for Laparoscopic Lymphadenectomy of Aortic Nodes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitari Vall d'Hebron Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fundación Mutua Madrileña</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Universitari Vall d'Hebron Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether the extraperitoneal approach is better than
      the transperitoneal approach for laparoscopic aortic lymphadenectomy for the surgical staging
      of endometrial or ovarian cancer.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2012</start_date>
  <completion_date type="Actual">April 2015</completion_date>
  <primary_completion_date type="Actual">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of lymph nodes</measure>
    <time_frame>After aortic lymphadenectomy is completed</time_frame>
    <description>The number of lymph nodes (absolute number) is specified by the pathologist on histopathological analysis of the sample sent by the surgeon after surgical staging is realized (laparoscopic aortic lymphadenectomy). This variable is subdivided into: supra-mesenteric and infra-mesenteric.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Operative time</measure>
    <time_frame>At the time of the surgery</time_frame>
    <description>Total duration of surgery (from initial skin incision to end of skin suture), and total aortic lymphadenectomy time (time spent since the beginning of aortic lymphadenectomy to its completion). Metric: minutes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraoperative complications</measure>
    <time_frame>At the time of surgery</time_frame>
    <description>Number of patients presenting intraoperative complications. This variable is also classified according to the type of adverse outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Early Postoperative complications</measure>
    <time_frame>within 30 days after surgery</time_frame>
    <description>Number of patients presenting postoperative complications. This variable is also classified according to the type of adverse outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Late Postoperative complications</measure>
    <time_frame>past 30 days after surgery</time_frame>
    <description>Number of patients presenting postoperative complications. This variable is also classified according to the type of adverse outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall survival</measure>
    <time_frame>up to 3 years</time_frame>
    <description>Number of patients alive after surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disease-free survival</measure>
    <time_frame>up to 3 years</time_frame>
    <description>Metric: months. Period of time in which there is no appearance of the symptoms or effects of the disease.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Endometrial Neoplasms</condition>
  <condition>Ovarian Neoplasms</condition>
  <arm_group>
    <arm_group_label>Transperitoneal</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients who where randomized to transperitoneal laparoscopic aortic lymphadenectomy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Extraperitoneal</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients who where randomized to extraperitoneal laparoscopic aortic lymphadenectomy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transperitoneal laparoscopic aortic lymphadenectomy</intervention_name>
    <description>Aortic/para-aortic lymph nodes dissection and retrieval by transperitoneal laparoscopy; the intervention may be completed by robotic-assisted or traditional laparoscopy.</description>
    <arm_group_label>Transperitoneal</arm_group_label>
    <other_name>Transperitoneal laparoscopic para-aortic lymphadenectomy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Extraperitoneal laparoscopic aortic lymphadenectomy</intervention_name>
    <description>Aortic/para-aortic lymph nodes dissection and retrieval by extraperitoneal laparoscopy; the intervention may be completed by robotic-assisted or traditional laparoscopy.</description>
    <arm_group_label>Extraperitoneal</arm_group_label>
    <other_name>Extraperitoneal laparoscopic para-aortic lymphadenectomy</other_name>
    <other_name>Retroperitoneal laparoscopic aortic lymphadenectomy</other_name>
    <other_name>Retroperitoneal laparoscopic para-aortic lymphadenectomy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of endometrial cancer confirmed by histopathological analysis (endometrial
             biopsy) requiring surgical staging according to FIGO (the International Federation of
             Gynecology and Obstetrics) recommendations

          -  Diagnosis of ovarian cancer confirmed by histopathological analysis after an initial
             cystectomy or oophorectomy without suspicion of neoplasia thus requiring additional
             surgical staging according to FIGO recommendations

        Exclusion Criteria:

          -  Diagnosis of advanced endometrial cancer based on findings on imaging techniques (CT,
             MRI and/or PET)

          -  Diagnosis of advanced endometrial or ovarian cancer based on intraoperative findings
             (e.g. peritoneal carcinomatosis at initial laparoscopy)

          -  Patients who underwent previous aortic lymphadenectomy

          -  Patients who received previous pelvic and/or aortic radiotherapy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antonio Gil Moreno, M.D., PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital Universitari Vall d'Hebron. Universitat Autonoma de Barcelona</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Berta Díaz Feijoo, M.D., PhD</last_name>
    <role>Study Director</role>
    <affiliation>Hospital Universitari Vall d'Hebron. Universitat Autonoma de Barcelona</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jose Luis Sánchez, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitari Vall d'Hebron. Universitat Autonoma de Barcelona</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alejandro Correa Paris, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitari Vall d'Hebron. Universitat Autonoma de Barcelona</affiliation>
  </overall_official>
  <overall_official>
    <last_name>M. Assumpció Pérez-Benavente, M.D., PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitari Vall d'Hebron. Universitat Autonoma de Barcelona</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Silvia Cabrera Díaz, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitari Vall d'Hebron. Universitat Autonoma de Barcelona</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Silvia Franco Camps, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitari Vall d'Hebron. Universitat Autonoma de Barcelona</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Oriol Puig Puig, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitari Vall d'Hebron. Universitat Autonoma de Barcelona</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Universitari Vall d'Hebron. Universitat Autonoma de Barcelona</name>
      <address>
        <city>Bacelona</city>
        <state>Barcelona</state>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Gil-Moreno A, Franco-Camps S, Cabrera S, Pérez-Benavente A, Martínez-Gómez X, Garcia A, Xercavins J. Pretherapeutic extraperitoneal laparoscopic staging of bulky or locally advanced cervical cancer. Ann Surg Oncol. 2011 Feb;18(2):482-9. doi: 10.1245/s10434-010-1320-9. Epub 2010 Sep 14.</citation>
    <PMID>20839058</PMID>
  </reference>
  <reference>
    <citation>Gil-Moreno A, Díaz-Feijoo B, Pérez-Benavente A, del Campo JM, Xercavins J, Martínez-Palones JM. Impact of extraperitoneal lymphadenectomy on treatment and survival in patients with locally advanced cervical cancer. Gynecol Oncol. 2008 Sep;110(3 Suppl 2):S33-5. doi: 10.1016/j.ygyno.2008.03.024. Epub 2008 Jun 5.</citation>
    <PMID>18538379</PMID>
  </reference>
  <reference>
    <citation>Gil-Moreno A, Maffuz A, Díaz-Feijoo B, Puig O, Martínez-Palones JM, Pérez A, García A, Xercavins J. Modified approach for extraperitoneal laparoscopic staging for locally advanced cervical cancer. J Exp Clin Cancer Res. 2007 Dec;26(4):451-8.</citation>
    <PMID>18365538</PMID>
  </reference>
  <reference>
    <citation>Gil-Moreno A, Díaz-Feijoo B, Morchón S, Xercavins J. Analysis of survival after laparoscopic-assisted vaginal hysterectomy compared with the conventional abdominal approach for early-stage endometrial carcinoma: a review of the literature. J Minim Invasive Gynecol. 2006 Jan-Feb;13(1):26-35.</citation>
    <PMID>16431320</PMID>
  </reference>
  <reference>
    <citation>Dowdy SC, Aletti G, Cliby WA, Podratz KC, Mariani A. Extra-peritoneal laparoscopic para-aortic lymphadenectomy--a prospective cohort study of 293 patients with endometrial cancer. Gynecol Oncol. 2008 Dec;111(3):418-24. doi: 10.1016/j.ygyno.2008.08.021. Epub 2008 Oct 2.</citation>
    <PMID>18835020</PMID>
  </reference>
  <reference>
    <citation>Magrina JF, Kho R, Montero RP, Magtibay PM, Pawlina W. Robotic extraperitoneal aortic lymphadenectomy: Development of a technique. Gynecol Oncol. 2009 Apr;113(1):32-5. doi: 10.1016/j.ygyno.2008.11.038. Epub 2009 Jan 21.</citation>
    <PMID>19157527</PMID>
  </reference>
  <reference>
    <citation>Franco-Camps S, Cabrera S, Pérez-Benavente A, Díaz-Feijoo B, Bradbury M, Xercavins J, Gil-Moreno A. Extraperitoneal laparoscopic approach for diagnosis and treatment of aortic lymph node recurrence in gynecologic malignancy. J Minim Invasive Gynecol. 2010 Sep-Oct;17(5):570-5. doi: 10.1016/j.jmig.2010.03.020. Epub 2010 Jun 30.</citation>
    <PMID>20580322</PMID>
  </reference>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 12, 2013</study_first_submitted>
  <study_first_submitted_qc>March 13, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 14, 2013</study_first_posted>
  <last_update_submitted>April 28, 2015</last_update_submitted>
  <last_update_submitted_qc>April 28, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 29, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>extraperitoneal</keyword>
  <keyword>transperitoneal</keyword>
  <keyword>laparoscopic aortic lymphadenectomy</keyword>
  <keyword>endometrial ovarian cancer</keyword>
  <keyword>ovarian cancer</keyword>
  <keyword>surgical staging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Ovarian Neoplasms</mesh_term>
    <mesh_term>Endometrial Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

